<div><b>Bibliographic references:</b></div><div>ALTEKRUSE, SF; HENLEY, SJ; CUCINELLI, JE; MCGLYNN, KA Changing
hepatocellular carcinoma incidence and liver cancer mortality rates in
the United States. American Journal of Gastroenterology. [ Sl ],
[2014], 542-553 p, v. 109, no. 4.</div><div>CHEDID, MF; KRUEL, CRP; PINTO, MA; GREZZANA-FILHO, TJM, LEIPNITZ, I.;
KRUEL, CDP; et al. Hepatocellular carcinoma: diagnosis and surgical
management. Brazilian Archives of Digestive Surgery [São Paulo].
[2017], 272-278 p, v. 30, no. 04.</div><div>FACCIORUSSO, A.; LICINIO, R.; MUSCATIELLO, N.; DI LEO, A.; BARONE, M.
Transarterial chemoembolization: Evidences from the literature and
applications in hepatocellular carcinoma patients. World Journal of
Hepatology. [ Sl ], [2015], 2009-2019 p, v. 7, no. 16.</div><div>HABIB, A.; DESAI, K.; HICKEY, R.; THORNBURG, B.; LEWANDOWSKI, R.; SALEM,
R. Locoregional therapy of hepatocellular carcinoma. Clin Liver Dis. [
Sl ], [2015], 401-420 p, v. 19, no. two.</div><div>LENCIONI, R. Chemoembolization for hepatocellular carcinoma. Seminars of
Oncology. [Italy], [2012], 503–509 p, v. 39, no. 4.</div><div>PARIKH, ND; WALJEE, AK; SINGAL, AG Downstaging hepatocellular carcinoma:
A systematic review and pooled analysis. Liver Transplantation. [ Ps
], [2015], 1142-1152 p, v. 21, no. 9.</div><div>RAOUL, JL; FORNER, A.; BOLONDI, L.; CHEUNG, TT; KLOECKNER, R.; DE BAERE,
T. Updated use of TACE for hepatocellular carcinoma treatment: How and
when to use it based on clinical evidence. Cancer Treatment Reviews. [
Ps ], [2019], 28-36 p.</div><div>SAN MIGUEL, C.; MUFFAK, K.; TRIGUERO, J.; BECERRA, A.; VILLEGAS, T.;
NOGUERAS, F.; et al. Role of Transarterial Chemoembolization to
Downstage Hepatocellular Carcinoma Within the Milan Criteria.
Transplantation Proceedings. [Ps], [2015], 2631-2633 p, v. 47,
no. 9.</div><div>TOWNSEND, CM; BEUCAMP, RD; EVERS, BM; MATTOX, KL Sabiston Textbook of
Surgery - The Biological Basis of Modern Surgical Practice. 20. ed. Rio
de Janeiro: Elsevier, 2019, 1457-1463 p.</div>